. . . . . "Vortioxetine" . . . "Schizophrenia" . . . . . . "The on‐label indication for Brintellix is depression; we identified the following off‐label indications: schizophrenia, episodic mood disorders, anxiety disorders, personality disorders, bipolar depression, post‐traumatic stress disorder, and chronic pain." . . . . . . . "Adults" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" . "XVqfM8Bl57qlTYmyajzYHRnNO8hFpg80YGKJ8o+oVDEu+6P3JHRf+NR8l3AIJnAlxjjKBi8m4ecJ59yxu9w+dUskiKCP8qVnKe2Nming7nXBodKX3tPPJc7xgOpYC58G5JEkppQcFTTvSwJuIcnbtT4VeDRiAJcKX7VbXYuJssw=" . . "2022-09-16T11:49:34.560461"^^ . . . "2.3.0" .